Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Current Assets: 2012-2025

Historic Current Assets for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to $1.0 billion.

  • Agios Pharmaceuticals' Current Assets fell 3.82% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 3.82%. This contributed to the annual value of $965.6 million for FY2024, which is 15.80% up from last year.
  • According to the latest figures from Q3 2025, Agios Pharmaceuticals' Current Assets is $1.0 billion, which was up 1.34% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Current Assets ranged from a high of $2.4 billion in Q1 2021 and a low of $632.1 million during Q2 2024.
  • Moreover, its 3-year median value for Current Assets was $833.8 million (2023), whereas its average is $858.5 million.
  • In the last 5 years, Agios Pharmaceuticals' Current Assets surged by 301.02% in 2021 and then crashed by 58.59% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Current Assets (Quarterly) stood at $1.1 billion in 2021, then dropped by 21.75% to $832.8 million in 2022, then climbed by 0.13% to $833.8 million in 2023, then grew by 15.80% to $965.6 million in 2024, then dropped by 3.82% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $968.6 million during Q1 2025.